Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction

Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction

Background: Stereotactic body radiation therapy (SBRT) delivers high doses of radiation to the prostate while minimizing radiation to adjacent critical organs. Large fraction sizes may increase urinary morbidity due to unavoidable treatment of the prostatic urethra. This study reports rates of acute...

Full description

Bibliographic Details
Main Authors: Michael Charles Repka, Shan eGuleria, Robyn A Cyr, Thomas M Yung, Harsha eKoneru, Leonard N Chen, Siyuan eLei, Brian Timothy Collins, Pranay eKrishnan, Simeng eSuy, Anatoly eDritschilo, John eLynch, Sean P. Collins
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-05-01
Series:Frontiers in Oncology
Subjects:
prostate cancer
CyberKnife
SBRT
Quality of life (QoL)
AUA symptom score
genitourinary toxicity
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00122/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00122/full

Similar Items